OppenheimerFunds’s AngioDynamics ANGO Stock Holding History

OppenheimerFunds’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$214K	Buy	+9,343	New	+$203K	﹤0.01%	1685
2018 Q4	–	Sell	-10,293	Closed	-$224K	–	1794
2018 Q3	$224K	Sell	10,293 -521	-5%	-$11.6K	﹤0.01%	1759
2018 Q2	$241K	Sell	10,814 -2,141	-17%	-$43.8K	﹤0.01%	1703
2018 Q1	$223K	Sell	12,955 -1,406	-10%	-$23.5K	﹤0.01%	1703
2017 Q4	$238K	Buy	14,361 +587	+4%	+$10K	﹤0.01%	1764
2017 Q3	$236K	Sell	13,774 -3,621	-21%	-$60.8K	﹤0.01%	1777
2017 Q2	$282K	Buy	17,395 +1,265	+8%	+$20K	﹤0.01%	1726
2017 Q1	$280K	Buy	16,130 +2,883	+22%	+$48.2K	﹤0.01%	1733
2016 Q4	$223K	Buy	+13,247	New	+$221K	﹤0.01%	1704
2016 Q3	–	Sell	-12,675	Closed	-$182K	–	1723
2016 Q2	$182K	Sell	12,675 -481	-4%	-$6.01K	﹤0.01%	1631
2016 Q1	$162K	Sell	13,156 -1,318	-9%	-$14.6K	﹤0.01%	1625
2015 Q4	$176K	Buy	+14,474	New	+$178K	﹤0.01%	1683

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

OppenheimerFunds's ANGO Position: Q1 2019 in Review

OppenheimerFunds opened a new position in AngioDynamics (ANGO) in Q1 2019: 9,343 shares worth $214K. The stake represents ﹤0.01% of the portfolio and ranks #1685 among its holdings. This is a return to the name: OppenheimerFunds previously reported a position in ANGO as recently as Q3 2018.

OppenheimerFunds first reported a position in ANGO in Q4 2015 and has held it in 12 quarters since. The position peaked at $282K in Q2 2017. 179 funds tracked by Wall St. Rank hold ANGO as of Q1 2019.

OppenheimerFunds held 9,343 shares of AngioDynamics worth $214K as of Q1 2019.
AngioDynamics was a new OppenheimerFunds position in Q1 2019.
AngioDynamics made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1685 holding.
OppenheimerFunds first reported a position in AngioDynamics in Q4 2015 and has held it in 12 quarters since.
OppenheimerFunds's AngioDynamics position peaked at $282K in Q2 2017.
179 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.